Download the iWounds at CX Symposium brochure to get all the details:
The sirolimus-eluting bioresorbable peripheral scaffold system (Prava; Elixir Medical) is designed to treat stenoses and occlusion in the superficial femoral artery. Prava was first implanted in October 2016 and will be clinically evaluated in the DESappear trial that has currently enrolled 21 patients at 11 […]
Meryl Davis, member of the CX Abstracts Board, talks about the invaluable opportunity for senior and trainee vascular and endovascular clinicians to present at the CX Abstract sessions.
Over four days, nine abstract and poster sessions covered topics including thoracic aortic, abdominal aortic, peripheral arterial, acute stroke and vascular access. Over 220 abstracts were presented by trainee and senior clinicians from 34 different countries.
Fadi Taher (Vienna, Austria) won the best Trainee Clinician Abstract […]
Yesterday, the CX ilegx Interdisciplinary Consensus on Severe Ischaemia explored all stages of managing severe limb ischaemia—looking at diagnosis, diabetic patients, and treatment options. This is in keeping with the ilegx’s goal of reducing the rate of amputations and tissue loss related to ischaemia.
The first session of […]
Day Two of the CX Venous Workshop showcased the latest technological advancements in the deep venous arena. Building on the success of Wednesday’s first-ever CX Venous Edited Cases, yesterday’s workshop included four more standing-room only expert case presentations looking at venous endovascular stenting and thrombectomy, as well […]
In traditional fashion, the CX Innovation Showcase did the job of raising important questions and challenges in the ever-developing and changing vascular and endovascular field. Chairmen Stephen Greenhalgh (London, UK) and Andrew Holden (Auckland, New Zealand) put together a far-reaching programme covering innovation and regulatory challenges, the […]
Described as “one of the best” courses of its kind in Europe, this year’s CX Vascular Access Skills course took delegates through each stage of the patient journey, from diagnosis, to treatment, to complication response, through a series of 20 specialist training stations.
“Our main aim was […]
There was a special session convened yesterday at CX to appreciate and recognise Edward B Diethrich’s life, untrammelled spirit, masterful surgical competence, and enormous influence in the cardiovascular field. The internationally esteemed cardiovascular surgeon, inventor, and philanthropist died on 23 February 2017 at the age of 81. […]
Experts in the Thoracic Aortic Plenary sessions yesterday discussed cutting-edge topics that lack support from strong data, making consensus difficult to achieve. Many unanswered questions were raised such as which patients with thoracic disease should get early vs. late treatment; whether centralisation of aortic services would tackle […]
Twelve posters selected for presentation out of 68 posters displayed were carefully reviewed by the CX Abstract Board, who decided to award their prize of a free CX 2018 registration to Daniela Mazzaccaro (San Donato Milanese, Italy) for her poster, “Study and patient specific prediction of the […]
The CX Venous Workshop returned on Wednesday, bigger than ever before. With a new location in the Exhibition Hall and its own series of edited live case presentations, it continues to showcase innovative venous technology and offer delegates the chance to get hands-on with the latest advances […]
For the first time, Day One of this year’s CX Venous Workshop included two edited case presentations (CX Venous Edited Cases). The standing-room only session gave delegates the opportunity to watch two innovative devices in action and quiz experienced surgeons on their top procedural tips.
Chaired by […]
First-time data presentation from the SWAN (Screening Women for Abdominal aNeurysms) project was heard at CX yesterday. The study, which used simulation to evaluate whether inviting women to be screened for abdominal aortic aneurysm would have clinical benefit, or be cost-effective, revealed that such a programme would […]
A “podium first” presentation of very long-term follow-up data from the EVAR 2 trials suggests that endovascular aneurysm repair (EVAR) fails to improve all-cause mortality, but reduces aneurysm-related mortality compared to no treatment in abdominal aortic aneurysm patients who are physically ineligible for open repair. The data […]
For the third time in CX Symposium history the London-based audience was transported via live video feed to Germany for real-time case presentations. This year CX connected with Arne Schwindt and Theodosios Bisdas in Münster, Germany, for four live peripheral cases alternated with edited cases.
The first live […]
In Tuesday’s CX Congenital Vascular Malformations session, delegates heard about how approaching congenital vascular malformations with systematic pathways of care and classification systems can greatly assist physicians in achieving consistently successful positive outcomes.
Joe Brookes (London, UK) presented on classification of arteriovenous malformations, charting its “emerging […]
The particular complexities of dealing with paediatric vessels were discussed in depth at Tuesday’s varied and informative CX Paediatric Vascular Emergencies and Case Presentations session. Covering topics as diverse as acute ischaemia from pre-term to infant and treatment for battlefield trauma in children, the session was one […]
Tuesday’s CX Aortic Edited Cases session featured exciting and engaging standing-room only case presentations, including Andrew Holden’s (Auckland, New Zealand) first-in-man implantation of the Ovation Alto (Endologix). Covering thoracic, juxtarenal and abdominal cases, the packed-out session explored innovative techniques, novel devices and a veritable array of practical […]
Delegates heard yesterday the results of the ATTRACT randomised controlled trial, which showed that the addition of catheter-based intervention to anticoagulation failed to significantly decrease the occurrence of post-thrombotic syndrome in deep vein thrombosis patients who received this treatment strategy when compared to its occurrence […]
Yesterday, delegates heard brand new data for drug-coated balloons (DCBs) in “wider use” scenarios such as challenging lesions; one-year results for a novel DCB; and late-breaking data on downstream coating effects of various DCBs. Still, 84% of the CX audience said “no” in response to the question: […]
The CX 2017 Peripheral Arterial Consensus Update Programme will focus on PATHWAYS OF CARE – whether to intervene, when and at what threshold, method and follow-up.
“Over three days (25–27 April) there will be a comprehensive coverage of the most important aspects of peripheral arterial intervention as well as some important new trial evidence being presented […]
Interventions in the aorta and manipulations in the aortic arch have become a “potential source of embolisation to the brain,” notes Roger Greenhalgh, Chairman of the CX Programme Organising Board. The Acute Stroke Consensus Plenary Programme will address the scope of this problem and PATHWAYS OF CARE to treat acute stroke from a multidisciplinary perspective including: […]
Vascular and endovascular thought-leaders Andrew Holden, Thomas Zeller, Stephen Black, Ian Franklin, Nicholas Inston, Matt Thompson and Giovanni Torsello share their views on what makes CX so special.
What makes CX so special for you? Tweet your comments @CXSymposium #CXisspecial
Don’t miss CX2017! Click here to register […]
The CX 2017 Venous Consensus Update Programme will focus on PATHWAYS OF CARE – whether to intervene, when and at what threshold, method and follow-up, providing delegates with discussions on diagnosis and treatment options for the whole spectrum of venous disease.
Roger Greenhalgh (Chairman, CX Programme Organising Board) discusses with Stephen Black (member, CX Programme Organising […]